Gilead Sciences
GILD
#129
Rank
ยฃ112.83 B
Marketcap
ยฃ90.94
Share price
-1.14%
Change (1 day)
27.06%
Change (1 year)

Gilead Sciences (GILD) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ18.70 Billion

According to Gilead Sciences's latest financial reports the company's total debt is ยฃ18.70 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Gilead Sciences - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ21.28 B8.53%
2023-12-31ยฃ19.61 B-5.95%
2022-12-31ยฃ20.85 B5.45%
2021-12-31ยฃ19.77 B-14.16%
2020-12-31ยฃ23.03 B22.84%
2019-12-31ยฃ18.75 B-12.87%
2018-12-31ยฃ21.52 B-13.27%
2017-12-31ยฃ24.81 B16.24%
2016-12-31ยฃ21.35 B43.47%
2015-12-31ยฃ14.88 B86.8%
2014-12-31ยฃ7.96 B98.04%
2013-12-31ยฃ4.02 B-20.93%
2012-12-31ยฃ5.08 B3.96%
2011-12-31ยฃ4.89 B116.81%
2010-12-31ยฃ2.25 B192.62%
2009-12-31ยฃ0.77 B-2.55%
2008-12-31ยฃ0.79 B19.88%
2007-12-31ยฃ0.66 B-8.3%
2006-12-31ยฃ0.72 B312.78%
2005-12-31ยฃ0.17 B80607.51%
2004-12-31ยฃ0.21 M-99.89%
2003-12-31ยฃ0.19 B-48%
2002-12-31ยฃ0.37 B113.78%
2001-12-31ยฃ0.17 B1.57%
2000-12-31ยฃ0.17 B214.13%
1999-12-31ยฃ54.44 M-10.8%
1998-12-31ยฃ61.04 M3033.53%
1997-12-31ยฃ1.94 M-48.68%
1996-12-31ยฃ3.79 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
ยฃ40.94 B 118.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ1.37 B-92.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ51.56 B 175.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ1.93 B-89.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ4.94 B-73.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ45.64 B 143.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ34.35 B 83.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ31.88 B 70.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ31.03 B 65.89%๐Ÿ‡บ๐Ÿ‡ธ USA